Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 391

1.

Safety and efficacy of long-term treatment with teneligliptin: Interim analysis of a post-marketing surveillance of more than 10,000 Japanese patients with Type 2 diabetes mellitus.

Kadowaki T, Haneda M, Ito H, Ueno M, Matsukawa M, Yamakura T, Sasaki K, Kimura M, Iijima H.

Expert Opin Pharmacother. 2017 Dec 21. doi: 10.1080/14656566.2017.1420165. [Epub ahead of print]

PMID:
29268035
2.

Patient knowledge and adherence to maintenance hemodialysis: an International comparison study.

Miyata KN, Shen JI, Nishio Y, Haneda M, Dadzie KA, Sheth NR, Kuriyama R, Matsuzawa C, Tachibana K, Harbord NB, Winchester JF.

Clin Exp Nephrol. 2017 Nov 28. doi: 10.1007/s10157-017-1512-8. [Epub ahead of print]

PMID:
29185127
3.

Nationwide multicenter kidney biopsy study of Japanese patients with hypertensive nephrosclerosis.

Furuichi K, Shimizu M, Yuzawa Y, Hara A, Toyama T, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ubara Y, Hoshino J, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Kohagura K, Ogawa D, Mise K, Shibagaki Y, Kimura K, Haneda M, Makino H, Matsuo S, Wada T; Research Group of Diabetic Nephropathy and Nephrosclerosis, Ministry of Health, Labour and Welfare of Japan, and Japan Agency for Medical Research and Development.

Clin Exp Nephrol. 2017 Nov 11. doi: 10.1007/s10157-017-1496-4. [Epub ahead of print]

PMID:
29127556
4.

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.

Ueki K, Sasako T, Okazaki Y, Kato M, Okahata S, Katsuyama H, Haraguchi M, Morita A, Ohashi K, Hara K, Morise A, Izumi K, Ishizuka N, Ohashi Y, Noda M, Kadowaki T; J-DOIT3 Study Group.

Lancet Diabetes Endocrinol. 2017 Dec;5(12):951-964. doi: 10.1016/S2213-8587(17)30327-3. Epub 2017 Oct 24.

PMID:
29079252
5.

Expression of transcription factors in MEN1-associated pancreatic neuroendocrine tumors.

Takeda Y, Fujita Y, Sakai K, Abe T, Nakamura T, Yanagimachi T, Sakagami H, Honjo J, Abiko A, Makino Y, Haneda M.

Endocrinol Diabetes Metab Case Rep. 2017 Sep 4;2017. pii: 17-0088. doi: 10.1530/EDM-17-0088. eCollection 2017.

6.

Association between all-cause mortality and severity of depressive symptoms in patients with type 2 diabetes: Analysis from the Japan Diabetes Complications Study (JDCS).

Matsunaga S, Tanaka S, Fujihara K, Horikawa C, Iimuro S, Kitaoka M, Sato A, Nakamura J, Haneda M, Shimano H, Akanuma Y, Ohashi Y, Sone H.

J Psychosom Res. 2017 Aug;99:34-39. doi: 10.1016/j.jpsychores.2017.05.020. Epub 2017 May 31.

PMID:
28712428
7.

Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA-T2D trial.

Groop PH, Cooper ME, Perkovic V, Hocher B, Kanasaki K, Haneda M, Schernthaner G, Sharma K, Stanton RC, Toto R, Cescutti J, Gordat M, Meinicke T, Koitka-Weber A, Thiemann S, von Eynatten M.

Diabetes Obes Metab. 2017 Nov;19(11):1610-1619. doi: 10.1111/dom.13041. Epub 2017 Jul 31.

8.

Prediabetes Exhibits Decreased Disposition Index Correlated with Deterioration of Glycemic Parameters in Nonobese Japanese Subjects: A Cross-Sectional Study from Medical Examination.

Takeda Y, Fujita Y, Yanagimachi T, Honjo J, Abiko A, Asai M, Haneda M.

Metab Syndr Relat Disord. 2017 Aug;15(6):296-303. doi: 10.1089/met.2016.0137. Epub 2017 Apr 24.

PMID:
28436739
9.

Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001-2010: Report of the Committee on Causes of Death in Diabetes Mellitus.

Nakamura J, Kamiya H, Haneda M, Inagaki N, Tanizawa Y, Araki E, Ueki K, Nakayama T.

J Diabetes Investig. 2017 May;8(3):397-410. doi: 10.1111/jdi.12645. Epub 2017 Mar 27.

10.

Nationwide multicentre kidney biopsy study of Japanese patients with type 2 diabetes.

Furuichi K, Yuzawa Y, Shimizu M, Hara A, Toyama T, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ubara Y, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Kohagura K, Ogawa D, Mise K, Shibagaki Y, Kimura K, Haneda M, Makino H, Matsuo S, Wada T.

Nephrol Dial Transplant. 2017 Mar 2. doi: 10.1093/ndt/gfw417. [Epub ahead of print]

PMID:
28340221
11.

Dipeptidyl peptidase-4 inhibitor treatment induces a greater increase in plasma levels of bioactive GIP than GLP-1 in non-diabetic subjects.

Yanagimachi T, Fujita Y, Takeda Y, Honjo J, Sakagami H, Kitsunai H, Takiyama Y, Abiko A, Makino Y, Kieffer TJ, Haneda M.

Mol Metab. 2016 Dec 31;6(2):226-231. doi: 10.1016/j.molmet.2016.12.009. eCollection 2017 Feb.

12.

Cyclin-Dependent Kinase Inhibitor-1-Deficient Mice are Susceptible to Osteoarthritis Associated with Enhanced Inflammation.

Kihara S, Hayashi S, Hashimoto S, Kanzaki N, Takayama K, Matsumoto T, Chinzei N, Iwasa K, Haneda M, Takeuchi K, Nishida K, Kuroda R.

J Bone Miner Res. 2017 May;32(5):991-1001. doi: 10.1002/jbmr.3080. Epub 2017 Jan 27.

PMID:
28128866
13.

Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled Trial.

Uzu T, Araki SI, Kashiwagi A, Haneda M, Koya D, Yokoyama H, Kida Y, Ikebuchi M, Nakamura T, Nishimura M, Takahara N, Obata T, Omichi N, Sakamoto K, Shingu R, Taki H, Nagai Y, Tokuda H, Kitada M, Misawa M, Nishiyama A, Kobori H, Maegawa H; Shiga Committee for Preventing Diabetic Nephropathy.

PLoS One. 2016 Dec 29;11(12):e0164936. doi: 10.1371/journal.pone.0164936. eCollection 2016.

14.

Hypothalamic AMP-Activated Protein Kinase Regulates Biphasic Insulin Secretion from Pancreatic β Cells during Fasting and in Type 2 Diabetes.

Kume S, Kondo M, Maeda S, Nishio Y, Yanagimachi T, Fujita Y, Haneda M, Kondo K, Sekine A, Araki SI, Araki H, Chin-Kanasaki M, Ugi S, Koya D, Kitahara S, Maeda K, Kashiwagi A, Uzu T, Maegawa H.

EBioMedicine. 2016 Oct 28. pii: S2352-3964(16)30499-6. doi: 10.1016/j.ebiom.2016.10.038. [Epub ahead of print]

15.

Hypothalamic AMP-Activated Protein Kinase Regulates Biphasic Insulin Secretion from Pancreatic ? Cells during Fasting and in Type 2 Diabetes.

Kume S, Kondo M, Maeda S, Nishio Y, Yanagimachi T, Fujita Y, Haneda M, Kondo K, Sekine A, Araki SI, Araki H, Chin-Kanasaki M, Ugi S, Koya D, Kitahara S, Maeda K, Kashiwagi A, Uzu T, Maegawa H.

EBioMedicine. 2016 Nov;13:168-180. doi: 10.1016/j.ebiom.2016.10.038. Epub 2016 Oct 28.

16.

New glycemic targets for patients with diabetes from the Japan Diabetes Society.

Araki E, Haneda M, Kasuga M, Nishikawa T, Kondo T, Ueki K, Kadowaki T.

J Diabetes Investig. 2017 Jan;8(1):123-125. doi: 10.1111/jdi.12600. Epub 2016 Dec 9.

17.

MicroRNA148b-3p inhibits mTORC1-dependent apoptosis in diabetes by repressing TNFR2 in proximal tubular cells.

Kuwagata S, Kume S, Chin-Kanasaki M, Araki H, Araki S, Nakazawa J, Sugaya T, Koya D, Haneda M, Maegawa H, Uzu T.

Kidney Int. 2016 Dec;90(6):1211-1225. doi: 10.1016/j.kint.2016.06.036. Epub 2016 Aug 31.

PMID:
27591086
18.

Patients with type 2 diabetes having higher glomerular filtration rate showed rapid renal function decline followed by impaired glomerular filtration rate: Japan Diabetes Complications Study.

Moriya T, Tanaka S, Sone H, Ishibashi S, Matsunaga S, Ohashi Y, Akanuma Y, Haneda M, Katayama S.

J Diabetes Complications. 2017 Feb;31(2):473-478. doi: 10.1016/j.jdiacomp.2016.06.020. Epub 2016 Jun 29.

PMID:
27396240
19.

Sodium-Glucose Cotransporter 2 Inhibitor and a Low Carbohydrate Diet Affect Gluconeogenesis and Glycogen Content Differently in the Kidney and the Liver of Non-Diabetic Mice.

Atageldiyeva K, Fujita Y, Yanagimachi T, Mizumoto K, Takeda Y, Honjo J, Takiyama Y, Abiko A, Makino Y, Haneda M.

PLoS One. 2016 Jun 21;11(6):e0157672. doi: 10.1371/journal.pone.0157672. eCollection 2016.

20.

[Emerging new aspects on diabetic nephropathy].

Takiyama Y, Haneda M.

Nihon Rinsho. 2016 Apr;74 Suppl 2:158-63. Japanese. No abstract available.

PMID:
27266080

Supplemental Content

Loading ...
Support Center